Microvolume Analysis of Aflibercept in Aqueous Humor Using Mass Spectrometry Translational Vision Science & […]
Reversal of immune-checkpoint inhibitor fulminant myocarditis using personalized-dose-adjusted abatacept and r […]
A rapid and universal liquid chromatograph-mass spectrometry-based platform, refmAb-Q nSMOL, for monitoring mo […]
Structure-Indicated LC-MS/MS Bioanalysis of Therapeutic Antibodies Methods Mol Biol. 2022;2313:187-205
Potential application of measuring serum infliximab levels in rheumatoid arthritis management: A retrospective […]
Use of an alternative signature peptide during development of a LC-MS/MS assay of plasma nivolumab levels appl […]
Trough levels of ipilimumab in serum as a potential biomarker of clinical outcomes for patients with advanced […]
Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor J Immunother […]
Bioanalytical methods for therapeutic monoclonal antibodies and antibody–drug conjugates: A review of recent a […]
A novel LC-MS/MS approach to the pharmacokinetic study of free and bound aflibercept simultaneously Analytical […]
Acceleration of nano-surface and molecular-orientation limited(nSMOL) proteolysis with acidified reduction pre […]
Comparison of Bevacizumab Quantification Results in Plasma of Non-small Cell Lung Cancer Patients Using Bioana […]
Plasma infliximab monitoring contributes to optimize Takayasu arteritis treatment: a case report Journal of Ph […]
Multiplexed monitoring of therapeutic antibodies for inflammatory diseases using Fab-selective proteolysis nSM […]
Regulated LC-MS/MS bioanalysis technology for therapeutic antibodies and Fc-fusion proteins using structure-in […]
Human endotrophin as a driver of malignant tumor growth JCI Insight. 2019;4(9):e125094
Antibody drug quantitation in coexistence with anti-drug antibodies on nSMOL bioanalysis Analytical Biochemist […]
Recent advances in mass spectrometry-based approaches for proteomics and biologics: Great contribution for dev […]
Verification between Original and Biosimilar Therapeutic Antibody Infliximab Using nSMOL Coupled LC-MS Bioanal […]
Application of nSMOL coupled with LC‐MS bioanalysis for monitoring the Fc‐fusion biopharmaceuticals Etanercept […]
What sample preparation should be chosen for targeted MS monoclonal antibody quantification in human serum? Bi […]
LC–MS bioanalysis of Trastuzumab and released emtansine usingnano-surface and molecular-orientation limited (n […]
The 8th Japan Bioanalysis Forum symposium Bioanalysis (2017) 9(22), 1733–1737
Development of an LC-MS/MS method with protein G purification strategy for quantifying bevacizumab in human pl […]
Validated LC/MS Bioanalysis of Rituximab CDR Peptides Using Nanosurface and Molecular-Orientation Limited (nSM […]
Validated LC–MS/MS analysis of immune checkpoint inhibitorNivolumab in human plasma using a Fab peptide-select […]
Multiplex LCMS Bioanalysis of Brentuximab Vedotin, Rituximab and Cetuximab towards Therapeutic Drug Monitoring […]
Application of nano-surface and molecular-orientation limited proteolysis to LC?MS bioanalysis of cetuximab. B […]
Fully validated LCMS bioanalysis of Bevacizumab in human plasma using nano-surface and molecular-orientation l […]
The development of the validated LCMS bioanalysis of trastuzumab in human plasma using a selective detection m […]
Selective detection of complementaritydetermining regions of monoclonal antibody by limiting protease access t […]
PAGE TOP
